SPONSOR
Kanglin Biotechnology (Hangzhou) Co., Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Transfusion-dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Transfusion-dependent Beta-Thalassemia.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Kanglin Biotechnology (Hangzhou) Co., Ltd.
How many clinical trials has Kanglin Biotechnology (Hangzhou) Co., Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Kanglin Biotechnology (Hangzhou) Co., Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Transfusion-dependent Beta-Thalassemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Kanglin Biotechnology (Hangzhou) Co., Ltd. research focus on?
Kanglin Biotechnology (Hangzhou) Co., Ltd. clinical trials span Transfusion-dependent Beta-Thalassemia. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Kanglin Biotechnology (Hangzhou) Co., Ltd. clinical trial?
To participate in a Kanglin Biotechnology (Hangzhou) Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Kanglin Biotechnology (Hangzhou) Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Kanglin Biotechnology (Hangzhou) Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology